Literature DB >> 18436465

[Dosimetric evaluation of an automatic segmentation tool of pelvic structures from MRI images for prostate cancer radiotherapy].

D Pasquier1, T Lacornerie, N Betrouni, M Vermandel, J Rousseau, E Lartigau.   

Abstract

PURPOSE: An automatic segmentation tool of pelvic structures from MRI images for prostate cancer radiotherapy was developed and dosimetric evaluation of differences of delineation (automatic versus human) is presented here.
MATERIALS AND METHODS: CTV, rectum and bladder were defined automatically and by a physician in 20 patients. Treatment plans based on "automatic" volumes were transferred on "manual" volumes and reciprocally. Dosimetric characteristics of PTV (V(95), minimal, maximal and mean doses), rectum (V(50), V(70), maximal and mean doses) and bladder (V(70), maximal and mean doses) were compared.
RESULTS: Automatic delineation of CTV did not significantly influence dosimetric characteristics of "manual" PTV. Rectal V(50) and V(70) were not significantly different; mean rectal dose is slightly superior (43.2 versus 44.4Gy, p=0.02, Student test). Bladder V(70) was significantly superior too (19.3 versus 21.6, p=0.004). Organ-at-risk (OAR) automatic delineation had little influence on their dosimetric characteristics; rectal V(70) was slightly underestimated (20 versus 18.5Gy, p=0.001).
CONCLUSION: CTV and OAR automatic delineation had little influence on dosimetric characteristics. Software developments are ongoing to enable routine use and interobserver evaluation is needed.

Entities:  

Mesh:

Year:  2008        PMID: 18436465     DOI: 10.1016/j.canrad.2008.03.001

Source DB:  PubMed          Journal:  Cancer Radiother        ISSN: 1278-3218            Impact factor:   1.018


  1 in total

1.  Dosimetric assessment of an Atlas based automated segmentation for loco-regional radiation therapy of early breast cancer in the Skagen Trial 1: A multi-institutional study.

Authors:  Ahmed R Eldesoky; Giulio Francolini; Mette S Thomsen; Esben S Yates; Tine B Nyeng; Carine Kirkove; Claus Kamby; Egil S Blix; Mette H Nielsen; Zahra Taheri-Kadkhoda; Martin Berg; Birgitte V Offersen
Journal:  Clin Transl Radiat Oncol       Date:  2017-02-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.